Keywords: shire, new, river, soar, next-generation, adhd, drug
Shire and New River soar as next-generation ADHD drug gets tentative US approval
Article | 16 October 2006
US regulators have given tentative approval to a next-generation attention-deficit hyperactivity drug made by UK-based Shire. The Food and Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
